Younger atrial fibrillation (AFib) patients are most likely to benefit from more personalized, MRI-guided ablation treatments to correct irregular heart rhythms, according to a new artificial intelligence-guided analysis of results from the DECAAF II trial , one of the largest global studies of treatments for heart arrhythmias. Tulane University researchers presented the findings at the European Society of Cardiology (ESC) Congress 2023 in Amsterdam this week. There's been debate among physicians on whether going beyond traditional ablation treatments provides a benefit to patients.

https://www.miragenews.com/younger-afib-patients-benefit-from-ai-mri-1072468/

#miragenews